Selling Dietary Supplements in India
Selling dietary supplements (health supplements / nutraceuticals) in India requires compliance with the regulatory framework administered by the Food Safety and Standards Authority of India (FSSAI). These products are regulated as food rather than medicines. Understanding Indian health-supplement regulations is essential before placing products on the Indian market.
Indian Health Supplement / Nutraceutical Regulations: What Sellers Need to Know
Health supplements and nutraceuticals are governed by the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016 (and subsequent updates, including the 2022 framework). The FSSAI oversees licensing, product standards, labelling and claims.
All Food Business Operators (FBOs) manufacturing, importing or selling these products must hold a valid FSSAI licence (Central, State or registration, depending on scale and activity). Certain products or ingredients may require additional product approval or notification. Brands that treat Indian supplements as interchangeable with U.S. dietary supplements or EU food supplements frequently encounter compliance barriers. A clear understanding of the overall framework is therefore the necessary starting point.
Which Ingredients Can Be Used in Indian Health Supplements?
FSSAI maintains positive lists of permitted ingredients, additives, and schedules for vitamins, minerals, botanicals, probiotics, prebiotics and other substances. Only ingredients listed in the applicable schedules (and within prescribed limits) may be used.
Not every form or dosage accepted in other markets is automatically permitted. Certain plant parts (for example, specific restrictions on Ashwagandha leaves) or substances may be prohibited or limited. Maximum levels for many vitamins, minerals and other actives are defined. Indian requirements therefore demand careful checking of the current FSSAI schedules and any specific advisories.
Novel or Non-Traditional Ingredients
Ingredients not listed in the permitted schedules or those considered novel may require prior approval or additional safety data. India has specific provisions for novel foods under the FSSAI regulations. Relying solely on a history of safe use in a third country is not sufficient without meeting local requirements. Early assessment of whether any component may trigger novel-food or non-permitted-ingredient rules is a critical part of Indian compliance.
Labelling Requirements for Supplements in India
Labels must comply with the FSS (Labelling and Display) Regulations and the specific health-supplement rules. They must be in English or Hindi (or both) and include:
- The category declaration “Health Supplement” or “Nutraceutical” (as applicable)
- Complete ingredient list with quantities
- Nutritional information
- Recommended daily intake / dosage
- The mandatory disclaimer: “This product is not intended to diagnose, treat, cure or prevent any disease”
- FSSAI licence number and logo
- Manufacturer / importer details
- Batch number and expiry / best-before date
- Allergen information and other mandatory warnings
Incomplete, poorly translated or U.S.-style labels are common reasons for non-compliance.
Nutrition and Health Claims for Supplements in India
Claims must be truthful, clear and scientifically substantiated under the FSS (Advertising and Claims) Regulations. Disease-related claims (prevention, treatment or cure) are prohibited for health supplements. Only permitted functional or nutritional claims that meet FSSAI criteria may be used.
Many structure/function-style statements common in other markets are not automatically acceptable. Using unauthorized or disease-related claims is one of the highest-risk compliance areas. Brands must align all on-pack and promotional language with FSSAI-permitted claims.
Common Mistakes When Selling Supplements in India
Frequent errors include:
- Operating without a valid FSSAI licence
- Using ingredients or plant parts not listed in the permitted schedules
- Exceeding maximum levels for vitamins, minerals or other actives
- Making disease-related or unsubstantiated claims
- Omitting the mandatory “not intended to diagnose, treat, cure or prevent any disease” disclaimer
- Incomplete or non-compliant labelling (missing FSSAI number, incorrect category declaration, etc.)
These oversights often surface during inspections or market surveillance and can result in product recalls, licence suspension or costly reformulation.
How StrongBody AI + MultiMe Help Supplement Sellers Prepare for Indian Compliance
Preparing for Indian health-supplement regulations requires organized product information, clear mapping of ingredients against FSSAI schedules, careful claims review, and structured documentation for licensing and any required product approvals. StrongBody AI and MultiMe support sellers by providing a Digital Office environment in which product data, specifications and compliance-related files can be centralized. This helps teams build a clearer compliance path—identifying which issues require specialist regulatory input and which can be managed internally—before approaching the Indian market. Structured communication tools further assist in coordinating with partners and advisors during the readiness process.
Why India-ready Supplement Brands Gain More Value from a Health & Wellness Selling Ecosystem
Once a brand has addressed ingredients, labelling and claims under Indian rules, commercial success still depends on reaching the right customers. StrongBody AI offers a health- and wellness-oriented marketplace environment aligned with the positioning of many health supplements and nutraceuticals. MultiMe adds global discovery, multilingual communication, structured Requests and Offers, and transaction infrastructure. Together they allow India-ready brands to convert regulatory readiness into market access without having to construct an entire international sales stack from scratch.
Call to Action
Build Indian supplement compliance around permitted ingredients and limits, a valid FSSAI licence, accurate labelling (including the mandatory disclaimer), and authorized claims. Then turn that readiness into health-market opportunities by connecting with customers through StrongBody AI and MultiMe. Clear regulatory preparation combined with a focused selling ecosystem creates a stronger foundation for selling dietary / health supplements in India.